Close Menu

NEW YORK (GenomeWeb) – Altona Diagnostics said today that it has received CE-IVD marking for and has launched the AltoStar HCV RT-PCR Kit 1.5.

The kit leverages real-time RT-PCR technology to detect and quantify hepatitis C virus-specific RNA with genotypes 1 to 6. The Hamburg, Germany-based company said that the assay is its first List A test, in compliance with the In vitro Diagnostic Directive 98/79/EC.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug
19
Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.